Why Skills-First Leadership Is Replacing the Ivy League Playbook in the C-Suite
05/23/2025
No Comments
The old prestige pyramid—where Ivy League degrees and blue-chip consulting backgrounds paved the way to the CEO seat—is cracking.
February 5, 2021: A UK trial has been launched to know if vaccinating people with different coronavirus vaccines for their first and second doses works and the approach currently of using twice the same type of vaccine.
The aim is to be more flexible in providing vaccine rollout and deal with any potential disruption to supplies.
According to the scientists, mixing jabs could provide even better protection.
The vaccines minister said there would be no changes to the UK’s current approach until the summer.
Official guidance from the Joint Committee on Vaccination and Immunisation says anyone who took the Pfizer-BioNTech or Oxford-AstraZeneca jab should get the same vaccine for both doses.
Scientists have a reason to believe the new mixing approach being trialed may prove beneficial; some Ebola immunization programs involve mixing different jabs to improve protection.
Vaccine Minister Nadhim Zahawi told BBC Breakfast that mixing doses is “something that is done in the history” with other vaccines such as jabs for hepatitis, polio, measles, mumps, and rubella.
The chief investigator, Prof Matthew Snape from the University of Oxford, said the “tremendously exciting study” would provide information vital to vaccines’ rollout in the UK and around the world.
“It will be fascinating to see if the different delivery methods actually could lead to an enhanced immune response in human beings,” Snape said.
Scientists will watch and guide volunteers for side-effects and keep track of blood tests to see their immune systems respond.
Although the full study will continue for 13 months, the scientists will hopefully announce some initial findings by this June.
The old prestige pyramid—where Ivy League degrees and blue-chip consulting backgrounds paved the way to the CEO seat—is cracking.
Loud leaders once ruled the boardroom. Charisma was currency. Big talk drove big valuations.
But the CEOs who make history in downturns aren’t the ones with the deepest cuts
Companies invest millions in leadership development, yet many of their best executives leave within a few years. Why?
The most successful business leaders don’t just identify gaps in the market; they anticipate future needs before anyone else.
With technological advancements, shifting consumer expectations, and global interconnectedness, the role of business leaders
Investor confidence in France is deteriorating as political gridlock and budgetary uncertainty deepen.
The Fort McMurray First Nation Group of Companies is the wholly owned business entity of Fort McMurray 468 First Nation. It was established in 1987 as Christina River Enterprises, and the organization rebranded as FMFN Group in 2021. Providing Construction, Custodial, Petro-Canada Fuel & Convenience Store, and Transportation services to a broad portfolio of customers, the Group of Companies is creating financial stability and prosperity for the Nation.
Maushum Basu is a visionary leader who inspires his team with a clear, compelling purpose. Unafraid to take calculated risks, he understands that growth often stems from change and innovation. His deep commitment to both Airia Brands, Inc.
When speaking with Martin Paquette, one thing is immediately apparent: he’s honest. His transparency is refreshing. While many shy away from such vulnerability, Paquette sees it as a force to reckon with. The incredible emotional intelligence speaks to years of looking within—it’s also what allows him to acknowledge his mistakes gracefully and use them as opportunities to innovate.
Leave us a message
Subscribe
Fill the form our team will contact you
Advertise with us
Fill the form our team will contact you
